Berliner Institut für Gesundheitsforschung - Charité und Max-Delbrück-Centrum

Germany-wide Standards for Coronavirus Data

BIH and other health care actors have established the cocos initiative (Corona Component Standards) to bring together research results on COVID-19.

To the press release

How does pulmonary fibrosis develop?

Researchers*at the Charité, the BIH and in Heidelberg have succeeded in tracing the development of pulmonary fibrosis and the role of the protein NEDD4-2 in detail.

To the press release

Drosten receives award for science communication

Prof. Dr. Christian Drosten, BIH Professor and Director of the Institute of Virology at Charité, received an award from the DFG for outstanding scientific communication in the Covid19 pandemic.

To the press release

What Cells does the novel Coronavirus attack?

Researchers*at the BIH, the Charité and the Thorax Clinic of the University Hospital Heidelberg have investigated which cells in the lung can be attacked by the coronavirus SARS-CoV-2.

To the press release

Call: SPARK-BIH

We are looking forward to receiving applications for the third SPARK-BIH Call for projects to develop innovative therapies and diagnostics. Deadline is 18 June 2020.

To the Call

Our mission: Translation!

The mission of the BIH is medical translation: The BIH aims to translate findings from biomedical research into new approaches for personalised prediction, prevention and therapy and, conversely, to develop new research approaches from clinical observations. The goal is always the medical benefit for patients*.

More about the mission of the BIH

BIH closed in Spreepalais - Corona research at full speed

To protect against SARS-CoV-2, the BIH works largely in the home office. Meanwhile, research on Corona/COVID-19 is in full swing.

A new Chapter for the Berlin Institute of Health

Anja Karliczek and Michael Müller signed an administrative agreement on the integration of the BIH into Charité.